Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-06-28

Clinical Trial Update: A 96-hour Patch Test Study Using Healthy Human Volunteers to Assess the Skin Irritation Potential of 11 Topically Applied Formulations [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating skin irritation potential of 11 topically applied formulations in healthy volunteers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Molnlycke Health Care AB | Conditions: Skin Irritancy Potential | Phase 4 | Status: UNKNOWN